CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schiere, S.
Right arrow Articles by Wierda, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schiere, S.
Right arrow Articles by Wierda, J. M.

Canadian Journal of Anesthesia, Vol 44, 1138-1143, Copyright © 1997 by Canadian Anesthesiologists' Society

ARTICLES

Comparison of vecuronium with ORG 9487 and their interaction

S Schiere, L van den Broek, JH Proost, B Molenbuur and JM Wierda
Research Group for Experimental Anesthesiology and Clinical Pharmacology, University of Groningen, The Netherlands.

PURPOSE: To compare the pharmacodynamic behaviour of vecuronium with that of ORG 9487, we measured the time-course of action of equipotent doses of ORG 9487 and vecuronium and investigated their mutual interaction when given in succession. METHODS: Sixty ASA I-II patients were anaesthetized with thiopentone, fentanyl, halothane and nitrous oxide and assigned randomly to four groups. Each patient received an initial dose (ID) of either vecuronium (V) or ORG 9487 (O) followed by maintenance doses (MDn) of either V or O (ID/MD: O/O, V/O, O/V, and V/V). The time course of action was measured mechanomyographically, determining the duration until 25% recovery of the single twitch (DUR25). RESULTS: The onset time of an ID of ORG 9487 was shorter than that of an ID of vecuronium (96 vs 203 sec, P < 0.001). The DUR25 of the ID of ORG 9487 was less than half that of vecuronium (10.7 +/- 2.8 vs 28.8 +/- 6.1 min, P < 0.001). The DUR25 of MD1 and MD2 of ORG 9487 were shorter than those of vecuronium (O/O: 7.3 +/- 2.8 and 8.5 +/- 2.4 min; V/O: 12.7 +/- 3.3 and 11.5 +/- 3.5 min, vs O/V: 16.4 +/- 4.5 and 20.6 +/- 4.7 min; V/V: 18.8 +/- 3.0 and 20.1 +/- 3.8 min, respectively, P < 0.05). AN ID of vecuronium prolonged the DUR25 of MD1 and MD2 of ORG 9487 (P < 0.05). CONCLUSION: ORG 9487 is a muscle relaxant with a shorter duration of action than vecuronium. Maintenance doses of ORG 9487 are also shorter acting than roughly equipotent maintenance doses of vecuronium, irrespective of which relaxant is given initially.


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
E. W. Moore and J. M. Hunter
The new neuromuscular blocking agents: do they offer any advantages?
Br. J. Anaesth., December 1, 2001; 87(6): 912 - 925.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G. E. Larijani, F. Donati, G. Bikhazi, R. Bartkowski, C. A. Kenaan, B. Plaud, and M. E. Goldberg
A Multicenter Evaluation of the Time-Course of Action of Two Doses of Rapacuronium After Early and Late Reversal with Neostigmine
Anesth. Analg., August 1, 2001; 93(2): 370 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
S. E. Kern, R. J. Fragen, P. C. Fitzgerald, M. van Zeeland, and J. O. Johnson
Impact of the initial doses of rocuronium and pancuronium on subsequent maintenance for neuromuscular block
Can J Anesth, February 1, 2001; 48(2): 129 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Schiere, J. H. Proost, M. Schuringa, and J. M. K. H. Wierda
Pharmacokinetics and Pharmacokinetic-Dynamic Relationship Between Rapacuronium (Org 9487) and Its 3-Desacetyl Metabolite (Org 9488)
Anesth. Analg., March 1, 1999; 88(3): 640 - 640.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Canadian Anesthesiologists' Society.